Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 28% ± 11% | |
type I pneumocyte | 4 studies | 22% ± 9% | |
endothelial cell | 3 studies | 33% ± 14% | |
myeloid cell | 3 studies | 28% ± 7% | |
astrocyte | 3 studies | 19% ± 3% | |
oligodendrocyte | 3 studies | 16% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2918.54 | 1445 / 1445 | 100% | 25.95 | 183 / 183 |
intestine | 100% | 3522.13 | 966 / 966 | 99% | 15.61 | 524 / 527 |
skin | 100% | 3794.07 | 1809 / 1809 | 99% | 15.81 | 469 / 472 |
uterus | 100% | 2899.04 | 170 / 170 | 99% | 14.94 | 456 / 459 |
stomach | 100% | 2967.65 | 358 / 359 | 99% | 17.22 | 283 / 286 |
bladder | 100% | 2226.81 | 21 / 21 | 98% | 12.09 | 496 / 504 |
pancreas | 100% | 2596.25 | 328 / 328 | 98% | 9.68 | 174 / 178 |
prostate | 100% | 3106.74 | 245 / 245 | 96% | 7.77 | 484 / 502 |
breast | 100% | 2822.01 | 459 / 459 | 96% | 8.64 | 1074 / 1118 |
lung | 100% | 5442.87 | 578 / 578 | 96% | 11.38 | 1108 / 1155 |
thymus | 100% | 4954.74 | 653 / 653 | 94% | 7.45 | 569 / 605 |
ovary | 100% | 3068.91 | 180 / 180 | 93% | 9.08 | 401 / 430 |
brain | 94% | 2317.89 | 2490 / 2642 | 99% | 16.75 | 695 / 705 |
adrenal gland | 100% | 3453.63 | 258 / 258 | 87% | 7.18 | 200 / 230 |
liver | 100% | 2259.61 | 226 / 226 | 86% | 7.24 | 350 / 406 |
kidney | 100% | 4699.34 | 89 / 89 | 86% | 5.81 | 776 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.52 | 29 / 29 |
spleen | 100% | 5087.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.90 | 1 / 1 |
adipose | 100% | 2838.50 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 2162.73 | 798 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1739.63 | 1318 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 7.20 | 78 / 80 |
heart | 96% | 1792.84 | 827 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 3695.23 | 874 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0032259 | Biological process | methylation |
GO_0031507 | Biological process | heterochromatin formation |
GO_0032200 | Biological process | telomere organization |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0010467 | Biological process | gene expression |
GO_0046425 | Biological process | regulation of receptor signaling pathway via JAK-STAT |
GO_2000677 | Biological process | regulation of transcription regulatory region DNA binding |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0140956 | Molecular function | histone H3K79 trimethyltransferase activity |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0031151 | Molecular function | histone H3K79 methyltransferase activity |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DOT1L |
Protein name | Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1 like histone lysine methyltransferase Histone-lysine N-methyltransferase, H3 lysine-79 specific Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (Histone H3-K79 methyltransferase) |
Synonyms | KMT4 KIAA1814 |
Description | FUNCTION: Histone methyltransferase. Methylates 'Lys-79' of histone H3. Nucleosomes are preferred as substrate compared to free histones . Binds to DNA . . FUNCTION: Histone methyltransferase that specifically trimethylates histone H3 to form H3K79me3. This methylation is required for telomere silencing and for the pachytene checkpoint during the meiotic cell cycle by allowing the recruitment of RAD9 to double strand breaks. Nucleosomes are preferred as substrate compared to free histone. .; FUNCTION: Histone methyltransferase. Methylates 'Lys-79' of histone H3. . FUNCTION: Histone methyltransferase that specifically trimethylates histone H3 to form H3K79me3. This methylation is required for telomere silencing and for the pachytene checkpoint during the meiotic cell cycle by allowing the recruitment of RAD9 to double strand breaks. Nucleosomes are preferred as substrate compared to free histone. .; FUNCTION: Histone methyltransferase. Methylates 'Lys-79' of histone H3. . FUNCTION: Histone methyltransferase that specifically trimethylates histone H3 to form H3K79me3. This methylation is required for telomere silencing and for the pachytene checkpoint during the meiotic cell cycle by allowing the recruitment of RAD9 to double strand breaks. Nucleosomes are preferred as substrate compared to free histone. .; FUNCTION: Histone methyltransferase. Methylates 'Lys-79' of histone H3. . FUNCTION: Histone methyltransferase that specifically trimethylates histone H3 to form H3K79me3. This methylation is required for telomere silencing and for the pachytene checkpoint during the meiotic cell cycle by allowing the recruitment of RAD9 to double strand breaks. Nucleosomes are preferred as substrate compared to free histone. . |
Accessions | ENST00000457590.2 A0A1C9J735 A0A1C9J732 Q8TEK3 H7C2S2 ENST00000452696.5 A0A087X1A7 ENST00000398665.8 [Q8TEK3-2] ENST00000478937.3 A0A8I5QL06 C9JH95 V9GY76 ENST00000686010.1 ENST00000586024.1 |